|
Description
TRANSLATIONAL TECHNOLOGY DEVELOPMENT AWARDS
Project Award Amount $75,000 (Maximum)
Description of Grant Area
These pilot projects should involve development and/or translational application of innovative and novel technologies. Highest priority will be given to technologies that will benefit multiple applications from diverse disciplines (e.g., new bio-imaging methods for clinical studies, new techniques for high-density SNP genotyping, development of novel clinical and translational studies within campus cores). These grants are distinct from Novel Clinical/Translational Methods Catalyst Awards in requiring that methods are technological and requiring that plans are in place to make the new technology available to the UCSF community within a core resource.
Successful proposals will describe development or validation of novel technologies for performing or supporting clinical or translational research. Recipients are required to make the resulting technology available to the UCSF community by having the new technology developed in or transferred into existing research cores or the clinical laboratory. This must be described within the proposal.
Each funded grant will have a maximum budget of $75,000. Projects are for one year and are not renewable. A progress report is expected at the end of and one year following the funding period, identifying resulting publications and subsequent funding recruited to support the expanded/extended project. A report of shared core use is required at that time. Any resulting publication must directly cite CTSI SOS Center funding.
If equipment purchase is proposed, it is expected that cost for large pieces of equipment should be shared among several sources, including departmental funds, individual research grants, and Academic Senate.
This Award Category is similar to shared equipment. The distinction is that the this Category funds development of novel technology rather than shared equipment.
The proposed research must be clearly justified as being translational in nature.
Note: For Translational Technology Development Awards, priority is given to applicants who have never received funding in this category.
Eligibility
All UCSF and CTSI associated institutional faculty in any series , including professional research series, may apply. Residents, Fellows, and non-faculty staff (e.g. Specialists) may not apply as PI.
Budget : Maximum $75,000 total costs. For development of technologies which will be placed into core laboratories, the proposal should explain how cost sharing will be managed in the future (e.g. recharge, grant, departmental support).
Criteria for Evaluation of Applications
Translational Technology: The highest priority will be given to development and application of novel and innovative technologies that will have direct and timely application to clinical and translational research, and to the community. It is expected that technologies will be made available to the research community through existing or new UCSF research Cores or the Clinical Laboratory.
Effective collaboration: The involvement of scientists from multiple disciplines and partnering of basic and clinical scientists in the proposed technology development will be evaluated. Projects that involve multi-disciplinary collaborations and particularly partnerships among basic and translational scientists, will receive highest priority. Also considered will be collaborations between academic investigators and private sector or community partners leading to the development and clinical application of new technologies.
Contact:
Emanuela (Emy) Volpe
CTSI-SOS Center Program Administrator
Ph.: 415-514-0301
E-mail: sos@ucsf.edu
Description |